Mixed β-adrenergic blocker and serotonin 5HT1A-receptor antagonist. Prepn: NL 6601040; F. Troxler, A. Hofmann, US 3471515 (1966, 1969 both to Sandoz). HPLC determn in plasma: H. Smith, J. Chromatogr. 415, 95 (1987). Symposia on cardiovascular pharmacology and clinical studies: Am. Heart J. 104, Suppl. 2, pt. 2, 333-520 (1982); Br. J. Clin. Pharmacol. 13, Suppl. 2, 143S-450S (1982). Effect on serotonin levels in rat brain: L. J. Dreshfield et al., Neurochem. Res. 21, 557 (1996). Clinical trial with fluoxetine, q.v., in depression: V. Pérez et al., Lancet 349, 1594 (1997).
Antihypertensive; antianginal; antiarrhythmic; antiglaucoma.
β-Adrenergic Blocker; Antianginal; Antiarrhythmic; Antiglaucoma; Antihypertensive; Aryloxypropanolamine Derivatives